Matt Basko
Vice President, Investor Relations
Replay available
PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Q4 2025 earnings conference call, held 2026-02-25. Replay captured from the company's public earnings webcast.

Vice President, Investor Relations
Chief Executive Officer
Chief Financial Officer
Analyst, Piper Sandler
Analyst, Nephron Research
Analyst, TD Cowen
Analyst, Truist Securities
Analyst, William Blair
Analyst, Oppenheimer & Co.
Analyst, Jefferies
Analyst, Bank of America
Analysts, UBS
Analyst, LearLink Partners
Analyst, Wells Fargo
Good afternoon and welcome to the Procept by Robotics fourth quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. We will be facilitating a question and answer session toward the end of today's call. As a reminder, this call is being recorded for replay purposes. I would now like to turn the conference over to Matt Basko, Vice President, Investor Relations, for a few introductory comments. Please go ahead. Good afternoon, and thank you for joining Procept Biorobotics' fourth quarter 2025 earnings conference call. Presenting on today's call are Larry Wood, Chief Executive Officer, and Kevin Waters, Chief Financial Officer. Before we begin, I'd like to remind listeners that statements made on this conference call that relate to future plans, events, or performance are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995. While these four looking statements are based on management's current expectations and beliefs, these statements are subject to several risks, uncertainties, assumptions, and other factors that could cause results to differ materially from the expectations expressed on this conference call. These risks and uncertainties are disclosed in more detail in Procept Biorobotics filings with the Securities Exchange Commission, all of which are available online at www.sec.gov. Listeners are cautioned not to place under reliance on these forward-looking statements, which speak only as of today's date, February 24th, 2026. Except as required by law, Procept Biorobotics undertakes no obligation to update or revise any forward-looking statements to reflect new information, circumstances, or unanticipated events that may arise. During the call, we will also reference certain fina...